Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alpheus Medical
AddedFeb 17, 2024
UpdatedJun 18, 2026
Alpheus Medical

Alpheus Medical

Series A

Alpheus Medical: Innovating sonodynamic therapy for solid body cancers.

HQ
Oakdale, MN, US
Founded
2021
Overview
Compare
Fundraising
Employees
Website

Alpheus Medical, founded with the mission to revolutionize cancer treatment, focuses on developing a novel sonodynamic therapy platform specifically targeting solid body cancers, including glioblastoma (GBM). The company aims to address the significant unmet medical need in treating one of the most complex and deadly forms of cancer. By leveraging advanced therapeutic devices, Alpheus Medical seeks to improve survival rates and offer new hope to patients battling treatment-resistant cancers.

The company is supported by leading experts in brain cancer and has affiliations with prominent organizations such as the American Cancer Society (ACS) and the National Brain Tumor Society (NBTS). These collaborations underscore Alpheus Medical's credibility and commitment to advancing cancer treatment. The impact of their innovative approach has the potential to significantly alter the landscape of cancer therapy, particularly for those suffering from GBM, where traditional treatments have seen limited success.

Alpheus Medical - Similar Companies

Sonalasense logo

Sonalasense

sonalasense.com

Neurosonics Medical logo

Neurosonics Medical

Alsus Medical logo

Alsus Medical

Piraeus Medical logo

Piraeus Medical

Cordance Medical logo

Cordance Medical

Alphina Therapeutics logo

Alphina Therapeutics

Amphora Medical logo

Amphora Medical

amphoramedical.com

Aethlon Medical logo

Aethlon Medical

aethlonmedical.com

Alcyone Lifesciences logo

Alcyone Lifesciences

Alucent Biomedical logo

Alucent Biomedical

alucentmedical.com

Sonify Biosciences logo

Sonify Biosciences

NED Medical logo

NED Medical

nedmedical.com

Sonogen Medical logo

Sonogen Medical

sonogenmed.com

Sonix Medical Devices logo

Sonix Medical Devices

Alopexx logo

Alopexx

alopexx.com

Alpheus Medical - Quick Facts

Who are Alpheus Medical's competitors?

Companies similar to Alpheus Medical include Sonalasense, Neurosonics Medical, Alsus Medical and Piraeus Medical.

When was Alpheus Medical founded?

Alpheus Medical was founded in 2021.

Where is Alpheus Medical's headquarters located?

Alpheus Medical's headquarters is located in Oakdale, MN, US.

When was Alpheus Medical's last funding round?

Alpheus Medical's most recent funding round was for $14M (USD) in November 2022.

How much has Alpheus Medical raised to-date?

As of Nov 10, 2022, Alpheus Medical has raised a total of $30M (USD).

How many employees does Alpheus Medical have?

Alpheus Medical has 5 employees as of Feb 5, 2024.

Alpheus Medical - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified